The bowel management systems market is set to grow from US$ 1,745.5 Mn to US$ 2,391.4 Mn at a compounded annual growth rate of 3.6% from 2018 to 2026. Bowel disorder is a medical condition which affects the small intestine and large intestine. The common bowel disorders identified are irritable bowel syndrome, Crohn’s disease, celiac disease and intestinal obstruction. The disease etiology is unknown with alteration in the normal gut peristalsis resulting in chronic constipation and diarrhea.
"Excellent cleaning & hygiene maintenance and favorable reimbursement scenario drive the colostomy bags market"
Colostomy bags are required in patients undergone colon surgical procedure and a permanent stoma is created to clean stool. It will be the leading and fastest growing market during the forecast period owing to its inherent features such as excellent cleaning and hygiene maintained during disposal of stool. Favorable reimbursement scenario will also further propel the colostomy bags market growth. Colonic irrigation systems are being in tremendous demand in naturopathy clinics to achieve body detoxification and in pediatric patients suffering with chronic constipation. Nerve modulation devices are used to stimulate the sacral nerve to stimulate the gut peristaltic activity in disabled and paralyzed patients suffering with fecal incontinence.
"Sedentary lifestyle, stress and craving for fast food trigger bowel disease in the adult population worldwide"
Presently adult patient are ruling the patient type segment for bowel management systems market. Sedentary lifestyle, craving for fast food and stress induce bowel disease in the adult population worldwide. According to World Health Organization research findings the occurrence of Crohn’s disease is 6-15 per 100,000 people. It is more common I women in comparison to men population worldwide. Pediatric patients will be growing at a steady pace during the forecast period on account of features such as genetic predisposition, environmental factors and decreased gut mucosal immune response against commensal intestinal microbiota.
"Availability of diverse range bowel management systems products and less maintenance cost incurred drive the home care market"
Home care settings are reigning the end-user segment for bowel management systems market. Increasing geriatric population suffering with chronic constipation, availability of diverse range bowel management products and low maintenance cost incurred drive the home care market growth. There has been a significant rise in the number of hospitals and ambulatory surgery centers providing intestinal care owing to rising public health awareness, and huge funds provided by government healthcare agencies to cater medical requirements of patients suffering with bowel disorders in remote locations.
"Rising prevalence of inflammatory bowel disease (IBD) and domicile of major players drive the market growth in North America"
In the present scenario North America represents 35.6% share in the global bowel management systems market. According to the statistics provided by Center for Disease Control and Prevention (CDC), in 2016, approximately 1.3% of United States citizens were reported to be suffering with IBD such as Crohn’s disease and ulcerative colitis. The parameters that influence the market growth in North America are rising prevalence of IBD and domicile of major players such as Medtronic, Plc., C.R.Bard, Inc., 3M healthcare etc. As per the research findings published in the scientific journal BMC Gastroenterology the prevalence rate of constipation in Europe is 17.1%. Increasing geriatric population, sedentary lifestyle and unhealthy eating habits propel the bowel management systems market growth in European region. It is the second largest regional market with a share of 30.4%. Asia Pacific is reported to currently hold a share of 18.9% and is set to register significant growth in the near future owing to factors such as rising prevalence of irritable bowel syndrome and increasing medical tourism market.
Market leaders existing in bowel management systems market are Aquaflush Medical Limited, ConvaTec Group, Plc., Axonics Modulation Technologies, C.R.Bard, Inc., B.Braun Melsungen AG., Cogentix Medical, Inc., Coloplast A/S, 3M Healthcare, Medtronic, Plc. and Mederi Therapeutics, Inc.
Historical & Forecast Period
This study report represents analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Bowel Management Systems market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
ATTRIBUTE | DETAILS |
---|---|
Research Period | 2023-2033 |
Base Year | 2024 |
Forecast Period | 2025-2033 |
Historical Year | 2023 |
Unit | USD Million |
Segmentation | |
Product
| |
Patient
| |
End-User
| |
Region Segment (2023-2033; US$ Million)
|
Key questions answered in this report